Constipation and the Quality of Life in Conservatively Treated Chronic Kidney Disease Patients: A Cross-sectional Study

Background: Constipation is a common gastrointestinal disorder that in general population is associated with worse health-related quality of life (HRQoL).The epidemiology of constipation has not been reliably determined in conservatively-treated CKD patients.We aimed to determine the prevalence of constipation and constipation-related symptoms in conservatively-treated CKD patients, to find factors associated with their altered prevalence ratio (PR), and to verify the associations between constipation and HRQoL.Methods: In this cross-sectional study, 111 conservatively-treated CKD outpatients fulfilled questionnaires that included questions addressing HRQoL (SF-36v2®), constipation-related symptoms (The Patient Assessment of Constipation-Symptoms questionnaire), the Bristol stool form scale (BSFS), Rome III criteria of functional constipation (FC), and frequency of bowel movement (BM).Results: Depending on the used definition, the prevalence of constipation was 6.6-28.9%.Diuretics and paracetamol were independently associated with increased PR of BSFS-diagnosed constipation (PR 2.86, 95% CI 1.28-6.37,P = 0.01) and FC (PR 2.67, 95% CI 1.07-6.64,P = 0.035), respectively.The most commonly reported symptoms were bloating (50.9%) and straining to pass a BM (42.7%).Abdominal discomfort (37.3%) was independently associated with worse scores in all analyzed HRQoL domains.In multiple regressions, FC and having <7 BM/week, but not BSFS-diagnosed constipation, were associated with lower scores in several HRQoL domains.Conclusions: Constipation and related symptoms are prevalent in CKD patients.FC and decreased frequency of defecation, but not BSFS-diagnosed constipation, are associated with worse assessment of HRQoL in conservatively-treated CKD patients.